Jae H Kang1, Stephanie J Loomis2, Janey L Wiggs2, Walter C Willett3, Louis R Pasquale4. 1. Channing Division of Network Medicine, Department of Medicine, Brigham & Women's Hospital, and Harvard Medical School, Boston, Massachusetts. 2. Glaucoma Service, Massachusetts Eye and Ear, Boston, Massachusetts. 3. Channing Division of Network Medicine, Department of Medicine, Brigham & Women's Hospital, and Harvard Medical School, Boston, Massachusetts3Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts4Department of Epidemiology, Harvar. 4. Channing Division of Network Medicine, Department of Medicine, Brigham & Women's Hospital, and Harvard Medical School, Boston, Massachusetts2Glaucoma Service, Massachusetts Eye and Ear, Boston, Massachusetts.
Abstract
IMPORTANCE: Effective strategies for primary prevention are lacking for exfoliation glaucoma (EG), which is the most common type of secondary glaucoma. OBJECTIVE: To examine the association between B vitamin intake and EG or suspected EG (EG/SEG) risk. DESIGN, SETTING, AND PARTICIPANTS: National prospective cohort study using more than 20 years of follow-up data from the Nurses' Health Study (all female registered nurses) and the Health Professionals Follow-up Study (all male health professionals) from June 1, 1980, to May 31, 2010 (Nurses' Health Study) and January 1, 1986, to December 31, 2010 (Health Professionals Follow-up Study). We included a subset of 78,980 Nurses' Health Study women and 41,221 Health Professionals Follow-up Study men who were 40 years or older, free of glaucoma, had completed diet questionnaires, and reported eye examinations (follow-up rate, >85%). EXPOSURES: Cumulatively updated intake of B vitamins (folate, vitamin B6, and vitamin B12) as ascertained by repeated administration of validated questionnaires. MAIN OUTCOMES AND MEASURES: Incident cases of EG/SEG, totaling 399 (329 women and 70 men), were first identified with the questionnaires and were subsequently confirmed with medical records. Multivariable relative risks for EG/SEG were calculated in each cohort and then pooled with meta-analysis. RESULTS: Vitamin B₆ and vitamin B₁₂ intake was not associated with EG/SEG risk in pooled analyses (P = .52 and P = .99 for linear trend, respectively). However, a suggestive trend of a reduced risk was observed with higher intake of folate: compared with the lowest quintile of cumulatively averaged updated total folate intake, the multivariable relative risk for EG/SEG for the highest quintile (≥654 μg/d) was 0.75 (95% CI, 0.54-1.04; P = .02 for linear trend). These results were not materially altered after adjustment for vitamin B₆ and vitamin B₁₂ intake. An association was observed for supplemental folate intake but not for dietary folate only (P = .03 and P = .64 for linear trend, respectively). Greater frequency of multivitamin use showed a modest suggestive inverse association (current multivitamin use of ≥6 times per week vs nonuse multivariable relative risk, 0.84; 95% CI, 0.64-1.11; P = .06 for linear trend). CONCLUSIONS AND RELEVANCE: Higher total folate intake was associated with a suggestive lower risk for EG/SEG, supporting a possible causal role of homocysteine in EG/SEG.
IMPORTANCE: Effective strategies for primary prevention are lacking for exfoliation glaucoma (EG), which is the most common type of secondary glaucoma. OBJECTIVE: To examine the association between B vitamin intake and EG or suspected EG (EG/SEG) risk. DESIGN, SETTING, AND PARTICIPANTS: National prospective cohort study using more than 20 years of follow-up data from the Nurses' Health Study (all female registered nurses) and the Health Professionals Follow-up Study (all male health professionals) from June 1, 1980, to May 31, 2010 (Nurses' Health Study) and January 1, 1986, to December 31, 2010 (Health Professionals Follow-up Study). We included a subset of 78,980 Nurses' Health Study women and 41,221 Health Professionals Follow-up Study men who were 40 years or older, free of glaucoma, had completed diet questionnaires, and reported eye examinations (follow-up rate, >85%). EXPOSURES: Cumulatively updated intake of B vitamins (folate, vitamin B6, and vitamin B12) as ascertained by repeated administration of validated questionnaires. MAIN OUTCOMES AND MEASURES: Incident cases of EG/SEG, totaling 399 (329 women and 70 men), were first identified with the questionnaires and were subsequently confirmed with medical records. Multivariable relative risks for EG/SEG were calculated in each cohort and then pooled with meta-analysis. RESULTS: Vitamin B₆ and vitamin B₁₂ intake was not associated with EG/SEG risk in pooled analyses (P = .52 and P = .99 for linear trend, respectively). However, a suggestive trend of a reduced risk was observed with higher intake of folate: compared with the lowest quintile of cumulatively averaged updated total folate intake, the multivariable relative risk for EG/SEG for the highest quintile (≥654 μg/d) was 0.75 (95% CI, 0.54-1.04; P = .02 for linear trend). These results were not materially altered after adjustment for vitamin B₆ and vitamin B₁₂ intake. An association was observed for supplemental folate intake but not for dietary folate only (P = .03 and P = .64 for linear trend, respectively). Greater frequency of multivitamin use showed a modest suggestive inverse association (current multivitamin use of ≥6 times per week vs nonuse multivariable relative risk, 0.84; 95% CI, 0.64-1.11; P = .06 for linear trend). CONCLUSIONS AND RELEVANCE: Higher total folate intake was associated with a suggestive lower risk for EG/SEG, supporting a possible causal role of homocysteine in EG/SEG.
Authors: Stefan Bleich; Johannes Roedl; Nicolas Von Ahsen; Ursula Schlötzer-Schrehardt; Udo Reulbach; Georg Beck; Friedrich E Kruse; Gottfried O H Naumann; Johannes Kornhuber; Anselm G M Jünemann Journal: Am J Ophthalmol Date: 2004-07 Impact factor: 5.258
Authors: John H Fingert; Alan L Robin; Todd E Scheetz; Young H Kwon; Jeffrey M Liebmann; Robert Ritch; Wallace L M Alward Journal: Trans Am Ophthalmol Soc Date: 2016-08
Authors: Jeff J Huang; Jack E Geduldig; Erica B Jacobs; Tak Yee T Tai; Sumayya Ahmad; Nisha Chadha; Douglas F Buxton; Kateki Vinod; Barbara M Wirostko; Jae H Kang; Janey L Wiggs; Robert Ritch; Louis R Pasquale Journal: Ophthalmol Glaucoma Date: 2022-04-22
Authors: Michael A Hauser; Inas F Aboobakar; Yutao Liu; Shiroh Miura; Benjamin T Whigham; Pratap Challa; Joshua Wheeler; Andrew Williams; Cecelia Santiago-Turla; Xuejun Qin; Robyn M Rautenbach; Ari Ziskind; Michèle Ramsay; Steffen Uebe; Lingyun Song; Alexias Safi; Eranga N Vithana; Takanori Mizoguchi; Satoko Nakano; Toshiaki Kubota; Ken Hayashi; Shin-ichi Manabe; Shigeyasu Kazama; Yosai Mori; Kazunori Miyata; Nagahisa Yoshimura; Andre Reis; Gregory E Crawford; Francesca Pasutto; Trevor R Carmichael; Susan E I Williams; Mineo Ozaki; Tin Aung; Chiea-Chuen Khor; W Daniel Stamer; Allison E Ashley-Koch; R Rand Allingham Journal: Hum Mol Genet Date: 2015-08-25 Impact factor: 6.150
Authors: Jae H Kang; Trang VoPham; Francine Laden; Bernard A Rosner; Barbara Wirostko; Robert Ritch; Janey L Wiggs; Abrar Qureshi; Hongmei Nan; Louis R Pasquale Journal: J Glaucoma Date: 2020-06 Impact factor: 2.503
Authors: Diana Anna Dmuchowska; Karolina Pietrowska; Pawel Krasnicki; Tomasz Kowalczyk; Magdalena Misiura; Emil Tomasz Grochowski; Zofia Mariak; Adam Kretowski; Michal Ciborowski Journal: Front Mol Biosci Date: 2021-05-14
Authors: Gina N Wilson; Matthew A Smith; Denise M Inman; Christine M Dengler-Crish; Samuel D Crish Journal: Front Neurosci Date: 2016-11-03 Impact factor: 4.677